[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 17, Issue 6 (Iranian South Medical Journal 2015) ::
Iran South Med J 2015, 17(6): 1100-1112 Back to browse issues page
The Predictive role of omentin-1, visfatin and adiponectin in osteoporosis-associated bone loss in postmenopausal women: a prospective cohort study
Fariba Karimi1, Elnaz Aminfar2, Hussain Darabi2, Mohammadreza Kalantar hormozi2, Samad Akbarzadeh2, Katayon Vahdat2, Afshin Ostovar2, Majid Assadi3, Iraj Nabipour 4
1- The Endocrinology and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, IRAN
2- The Persian Gulf Tropical Medicine Research Center, Bushehr university of Medical Sciences, Bushehr, IRAN
3- The Persian Gulf Nuclear Medicine Research Center, Bushehr University of Medical Sciences, Bushehr , IRAN
4- The Persian Gulf Marine Biotechnology Research Center, Bushehr university of Medical Sciences, Bushehr, IRAN , inabipour@gmail.com
Abstract:   (3275 Views)

Background: There is conflicting evidence regarding adipocytokines in relation to bone mineral density (BMD) and osteoporotic fractures in women and men. Recently, we found that circulating omentin-1 levels had an inverse correlation with BMD at the lumbar spine in postmenopausal women. The main aim of this study was to investigate the predictive role of adipocytokines for bone loss and incident osteoporosis among postmenopausal women after a 5.8- year follow-up.

Material and methods: A total of 382 healthy postmenopausal women who participated in a prospective cohort study were followed for 5.8 years. Omentin-1, visfatin, adiponectin, and the receptor activator of nuclear factor-κB ligand (RANKL) were measured by highly specific enzyme-linked immunosorbent assay methods. BMD was determined for the lumbar spine (L2–L4) and the proximal femur using dual-energy X-ray absorptiometry.

Results: The femoral neck and lumbar spine bone loss at the 5.8-year follow-up were 1.0% and 3.4% per year.In logistic regression analysis, none of the studied adipocytokines predicted BMD at any skeletal sites or incident osteoporosis at the femoral neck or lumbar area after 5.8 year follow-up. However, RANKL levels predicted BMD at the lumbar spine (β=−0.19, p=0.003) and femoral neck (β=-0.341, p=0.018) after controlling for body mass index.

Conclusion: Serum levels of omentin-1, visfatin and adiponectin did not predict bone loss and incident osteoporosis among postmenopausal women.

Keywords: omentin-1, visfatin, adiponectin, menopause, bone density
Full-Text [PDF 573 kb]   (995 Downloads)    
Type of Study: Original | Subject: Musculoskeletal System
Received: 2014/12/18 | Accepted: 2014/12/18 | Published: 2014/12/18
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Karimi F, Aminfar E, Darabi H, Kalantar hormozi M, Akbarzadeh S, Vahdat K, et al . The Predictive role of omentin-1, visfatin and adiponectin in osteoporosis-associated bone loss in postmenopausal women: a prospective cohort study. Iran South Med J. 2015; 17 (6) :1100-1112
URL: http://ismj.bpums.ac.ir/article-1-626-en.html


Volume 17, Issue 6 (Iranian South Medical Journal 2015) Back to browse issues page
دانشگاه علوم پزشکی بوشهر، طب جنوب ISMJ

Iranian South Medical Journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License which allows users to read,
copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly

Copyright © 2017, Iranian South Medical Journal| All Rights Reserved

Persian site map - English site map - Created in 0.06 seconds with 32 queries by YEKTAWEB 3919